Eli Lilly’s Alzheimer’s therapy, donanemab, has received FDA approval, offering new hope for patients with early symptomatic Alzheimer’s disease. The newly approved treatment, branded Kisunla, is set to challenge existing therapies from Eisai and Biogen.  Clinical trials have shown Kisunla to be effective for individuals in the mild cognitive impairment or mild dementia stages of […] Continue reading ->
Digital cessation programmes, behavioural support, and medication for tobacco cessation in adults are some of the measures contained in first-ever guidelines to help people quit smoking published recently by the World Health Organization (WHO).  One in five adults – 1.25 billion users worldwide – consume various tobacco products such as  cigarettes, heated tobacco products, water […] Continue reading ->
While a vaccine exists to prevent human papillomavirus (HPV), the main cause of cervical cancer, over 20 therapeutic HPV vaccine candidates are currently in development. These therapeutic vaccines aim to “boost the body’s immune response so that it can either fight and clear high-risk strains of the virus or abnormal ‘precancerous’ cells,” according to the […] Continue reading ->